Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asubio Pharma Co. Ltd.

Division of Daiichi Sankyo Co. Ltd.
www.asubio.co.jp

Latest From Asubio Pharma Co. Ltd.

Daiichi Sankyo Hoping Its Post-Olmesartan Plan Comes Together

"I love it when a plan comes together," Hannibal Smith of TV show The A-Team used to say, a catchphrase which Daiichi Sankyo will be hoping is appropriate in around five years' time as it looks back on the results of its new mid-term strategy.

BioPharmaceutical Japan

Daiichi Sankyo New R&D Head Puts Emphasis On Faster Decision-making

Daiichi Sankyo has four large Phase III milestones in the next two years, followed by prioritization for early stage programs

BioPharmaceutical Japan
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Daiichi Sankyo Co. Ltd.
  • Senior Management
  • Seiichi Yokoyama, Pres. & CEO
  • Contact Info
  • Asubio Pharma Co. Ltd.
    Phone: (81)
    Tokyo,
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register